Insights
Insights From Our Experts
Articles
Breaking through Barriers: Critical Success Factors for Launching Products with Breakthrough Therapy Designation
Posted by
Siddharth Agrawal , Andrew Therrien, PhD , Mark D. Bogost , Vivienne Ho, PhD on July 26, 20217/26/21
The FDA’s Breakthrough Therapy Designation (BTD) expedites patient access to innovative new treatments. While speeding up these processes can get new drugs to patients in need faster than they normally would through standard tracks, limited clinical…
BLOG: Pharmaceutical Value-based Contracts: Adherence and Supportive Contracts
Posted by
Dr. Richard Stefanacci on July 20, 20217/20/21
While there is a great deal of talk regarding value-based contracts in the life sciences industry, there are few successful examples. The difficulties in structuring these contracts begin with identification of outcomes that are directly and…
Global Regulations Push Accelerated Approvals, Access and Treatment Distribution: June 2021
Improving patient access and treatment affordability is quickly becoming a global priority reflected in current regulatory actions. This month, the U.S. FDA approved Aduhelm (aducanumab) for Alzheimer’s through an Accelerated Approval pathway, which will open treatment opportunities for patients. Meanwhile, the world continues to push on…
BLOG: Medical vs. Pharmacy Benefit: A Look at UM Differences
Posted by
Dr. Richard Stefanacci on July 1, 20217/1/21
Medicare medical and pharmacy benefits are very different in their utilization management (UM). As such, it is valuable to know the distinctions between benefits, as strategies differ depending on which ones apply. The most significant differentiator…
Transform Your Medical Information Contact Center Into a Strategic Asset for Customer Engagement
The pharmaceutical industry is constantly evolving, and manufacturers are re‑strategizing, embracing technology and innovation, to meet the needs of the providers and patients they serve. Successful product launches on a global scale are critical for manufacturers…
PharmaVOICE Webinar: Next Gen Commercialization Model for Oncology
In a new 60-minute virtual panel, “Next Gen Commercial Models in Oncology,” PharmaVOICE Editor Taren Grom sat down with industry leaders to discuss how changing market dynamics and a rich pipeline in oncology are creating a…
Ask the Expert: One-on-One with Amy Hutnik
The pharma industry’s needs have evolved beyond one-dimensional playbooks, disconnected promotional efforts and limited ability to assess stakeholder engagement. Instead, manufacturers need to adopt a comprehensive omnichannel model that allows for data-driven planning and real-time analysis…
BLOG: Gaining Coverage for Emerging Medical Technologies
Posted by
Dr. Richard Stefanacci on June 15, 20216/15/21
The line between medical and personal care is everchanging. In all areas of our lives there is coverage through medical benefits, but the exact line between this and one’s personal responsibilities is not always as clear,…
Omnichannel: A Conversation With the Innovators
Go beyond marketing to provide actionable insights that better inform commercial strategies and elevate brand success. EVERSANA’s best-in-class omnichannel activation model aggregates and synthesizes pivotal datasets from marketing campaigns, patient services programs and field activities to analyze…
Pharma USA Webinars: Personalize HCP Experiences for Deeper Engagement
EVERSANA was proud to participate in two Pharma USA 2021 sessions. This webinar, featuring EVERSANA’s Amy Hutnik, General Manager, Agency, Advisory and Evidence Services, covers the following topics: Harnessing AI to inform your sales approach and…